
The weight-loss drug Wegovy has been approved in the UK for treating MASH-related liver fibrosis, a severe form of fatty liver disease characterized by excess fat accumulation in the liver, leading to inflammation and damage. This approval marks a significant development in addressing this health issue.
AI summary. Verify with the original source.
Read full story at Eastleigh Voice ↗
Listen
Unlock audio summaries, audio summaries, AI chat, Wikipedia facts, and ad-free reading.
$3.99 / month · cancel anytime
Go PremiumBackground facts
Unlock wikipedia facts, audio summaries, AI chat, Wikipedia facts, and ad-free reading.
$3.99 / month · cancel anytime
Go PremiumSimilar stories

A study has found that intermittent fasting, an eating pattern that emphasizes the timing of food intake rather than the type of food consumed, can help individuals maintain weight loss for at least a year. This method involves alternating between periods of eating and fasting, during which calorie-containing foods or drinks are not consumed.
Eastleigh Voice·July 4, 2026 at 3:21 PM
Medical experts in Nigeria have raised concerns about the increasing trend of self-medication, which they warn is exacerbating liver-related diseases and endangering millions of individuals. The indiscriminate use of painkillers, antibiotics, and herbal mixtures without proper medical supervision or diagnosis is contributing to this health crisis, according to the experts.
Vanguard (NG)·June 24, 2026 at 11:36 PM
A new implant has shown promising results for patients suffering from treatment-resistant depression, offering renewed hope for lasting recovery after years of ineffective treatments. This development could significantly impact the lives of thousands who have struggled with this condition, according to Eastleigh Voice.
Eastleigh Voice·July 4, 2026 at 12:21 PM
According to the WHO, the use of uterotonics immediately after childbirth helps reduce the risk of maternal deaths. The article discusses important measures to consider in preventing fatalities among pregnant women.
Nukta Africa·June 20, 2026 at 11:40 AM
Singer Vyroota has addressed concerns from fans regarding his significant weight loss, stating that it is not due to any illness. In an interview on Kasuku Live, he explained that he had previously gained weight and is now experiencing a natural reduction in size.
BigEye·July 4, 2026 at 8:37 AMThe Ministry of Health announced that demand for Lenacapavir, a new HIV prevention injection launched in April, is currently exceeding the available supply, particularly among men seeking the twice-yearly treatment. Dr. Herbert Kadama, who coordinates Pre-Exposure Prophylaxis (PrEP) at the Ministry, spoke at a meeting with HIV advocates, researchers, and policymakers about the situation.
HEJNU (UG)·June 19, 2026 at 9:01 AM